Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Organization and Evaluation of Performance Indicators of a Breast Cancer Screening Program in Meknes-Tafilalt Region, Morocco

  • Charaka, Hafida (Department of Epidemiology, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University) ;
  • Khalis, Mohamed (Department of Epidemiology, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University) ;
  • Elfakir, Samira (Department of Epidemiology, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University) ;
  • Khazraji, Youssef Chami (Foundation Lalla Salma Prevention and Treatment of Cancers) ;
  • Zidouh, Ahmed (Foundation Lalla Salma Prevention and Treatment of Cancers) ;
  • Abousselham, Loubna (Direction of Population, Ministry of Health) ;
  • El Rhazi, Karima (Department of Epidemiology, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University) ;
  • Lyoussi, Badiaa (Sidi Mohammed Ben Abdellah University) ;
  • Nejjari, Chakib (Department of Epidemiology, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University)
  • Published : 2016.12.01
⟨ Previous Next ⟩

Abstract

Objective: The benefits of screening and early detection of breast cancer, including reduced morbidity and mortality, have been well-reported in the literature. In 2011, a breast cancer screening program was launched in Meknes-Tafilalt region of Morocco. The aim of this study was to evaluate the early performance indicators of this program. Materials and Methods: This retrospective evaluative study was conducted between April 2012 and December 2014, in Meknes-Tafilalt region of Morocco. Several performance indicators of the breast cancer screening program were calculated: the compliance rate, the positivity rate, the referral rate, the cancer detection rate and the organizational indicators. Results: During 2012-2014, a total of 184,951 women participated in the breast cancer screening program. The compliance rate was 26%, the positive rate was 3.3%, the referral rate was 36.7%, and the cancer detection rate was 1.2 per 1,000 women. The median time between the date of clinical breast examination and the date of biopsy (or cyto-puncture) was 36 days. The median time between the date of positive mammography and the date of biopsy (or cyto-puncture) was 6 days. The median time between the date of clinical breast examination and the date of the first received treatment was 61 days. Conclusions: The program needs better monitoring, as well as implementation of quality assurance tools to improve performance in our country.

Keywords

References

  1. Baines CJ, Miller AB, Bassett AA (1989). Physical examination. Its role as a single screening modality in the Canadian National Breast Screening Study. Cancer, 63, 1816-22.
  2. Berardi R, Nacciarriti D, Tamburrano T, et al (2013). Compliance with breast and cervical cancer screening programs in women: results from a population-based study. Tumori, 99, 565-71 https://doi.org/10.1177/030089161309900501
  3. Bleyer A, Welch HG (2012). Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med 367, 1998-2005 https://doi.org/10.1056/NEJMoa1206809
  4. Bobo JK, Lee Nc Fau - Thames SF, Thames SF (2000). Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst, 92, 971-6. https://doi.org/10.1093/jnci/92.12.971
  5. Bouchbika Z, Haddad H, Benchakroun N, et al (2013). Cancer incidence in Morocco: report from Casablanca registry 2005-2007. Pan Afr Med J, 16, 31.
  6. Cancer Registry of Casablanca (2005-2007). Registre des cancers du grand Casablanca, Rapport 2005-2007. Available from: http://www.contrelecancer.ma/
  7. Cancer Registry of Rabat (2005). Incidence des cancers a Rabat 2005. Ministere de la Sante du Maroc; 2009.
  8. Cuzick J (2010). Breast cancer prevention in the developing world. Breast Cancer Res, 12, 4-9.
  9. Dundar PE, Ozyurt Bc Fau-Erdurak K, Erdurak K (2012). Sociodemographic determinants of nonattendance in a population-based mammography screening program in the city of Manisa, Turkey. Scientific World J, 89, 342-7.
  10. El Fakir S, Najdi A, Khazraji YC, et al (2015). Breast cancer screening in Morocco: performance indicators during two years of an organized programme. Asian Pac J Cancer Prev, 16, 6285-8. https://doi.org/10.7314/APJCP.2015.16.15.6285
  11. Ermiah E, Abdalla F, Buhmeida A, et al (2012). Diagnosis delay in Libyan female breast cancer. BMC Res Notes, 5, 452. https://doi.org/10.1186/1756-0500-5-452
  12. Ferlay J, Soerjomataram I, Dikshit R, et al (2015). Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer, 136, 359-86. https://doi.org/10.1002/ijc.29210
  13. Fondation Lalla Salma Prevention and Treatment of Cancers (2011). Guide de detection precoce des cancers du sein et du col de l'uterus au Maroc.
  14. Frikha M, Yaiche O, Elloumi F, et al (2013). Results of a pilot study for breast cancer screening by mammography in Sfax region, Tunisia. J Gynecol Obstet Biol Reprod (Paris), 42, 252-61 https://doi.org/10.1016/j.jgyn.2013.01.007
  15. Harounay YD (2001). La femme d'Afrique et son chirurgien face au cancer du sein. Med Afrique Noire 2001. Medecin d'Afrique Noire, 48, 76-9.
  16. Kawar LNNL (2013). Barriers to breast cancer screening participation among Jordanian and Palestinian american women. european journal of oncology nursing. Eur J Oncol Nurs, 17, 88-94.
  17. Khatcheressian LJ, Wolff CA, Smith K, et al (2006). American society of clinical oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. Journal of Clinical Oncology 24. J Clin Oncol, 24, 3187-205. https://doi.org/10.1200/JCO.2006.06.4451
  18. Lagerlund M, Sparen P, Thurfjell E (2000). Predictors of nonattendance in a population-based mammography screening programme; socio-demographic factors and aspects of health behaviour. Eur J Cancer Prev , 9, 25-33 https://doi.org/10.1097/00008469-200002000-00004
  19. Maalej M, Frikha H, Ben Salem S, et al (1999). Breast cancer in Tunisia: clinical and epidemiological study. Bull Cancer, 86, 302-6.
  20. Madlensky L, Goel V, Polzer J, Ashbury FD (2003). Assessing the evidence for organised cancer screening programmes. Eur J Cancer, 39, 1648-53. https://doi.org/10.1016/S0959-8049(03)00315-0
  21. Malek D, Kaab-Sanyal V (2016). Implementation of the German mammography screening program (German MSP) and first results for initial examinations, 2005-2009. Breast Care (Basel), 11, 183-7. https://doi.org/10.1159/000446359
  22. Mittra I (2011). Breast cancer screening in developing countries. Prev Med, 53, 121-2. https://doi.org/10.1016/j.ypmed.2011.06.010
  23. Morimoto TM, Sasa T, Yamaguchi HK, Fung YK, et al (1997). Effectiveness of mammographic screening for breast cancer in women aged over 50 years in Japan. Jpn J Cancer Res, Gann, 88, 778-84. https://doi.org/10.1111/j.1349-7006.1997.tb00450.x
  24. Moshina N, Ursin G, Roman M, Sebuodegard S, Hofvind S (2016). Positive predictive values by mammographic density and screening mode in the Norwegian Breast Cancer Screening Program. Eur J Radiol, 85, 248-54. https://doi.org/10.1016/j.ejrad.2015.11.030
  25. Nystrom L, Rutqvist LE, Wall S, et al (1993). Breast cancer screening with mammography: overview of Swedish randomised trials. Lancet, 341, 973-8. https://doi.org/10.1016/0140-6736(93)91067-V
  26. Pape R, Spuur KM, Umo P (2016). Factors contributing to low participation in mammography screening in Papua New Guinea. Radiography, 22, 151-8. https://doi.org/10.1016/j.radi.2016.04.012
  27. Pisani P, Parkin DM, Ngelangel C, et al (2006). Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int J Cancer, 118, 149-54. https://doi.org/10.1002/ijc.21343
  28. Potvin L, Louise CJ, Beland F, Francois D (1995). Patterns of health services utilization and mammography use among women aged 50 to 59 years in the Quebec Medicare system. Medical care, 24, 515-30.
  29. Rastad H, Khanjani N, Khandani BK (2012). Causes of delay in seeking treatment in patients with breast cancer in Iran: a qualitative content analysis study. Asian Pac J Cancer Prev, 13, 4511-5. https://doi.org/10.7314/APJCP.2012.13.9.4511
  30. Reginald HO, Miles M, Cuaresma C, Guerrero R, Agbayani A (2010). Addressing the excess breast cancer mortality in Filipino women in Hawai'i through AANCART, an NCI community network program. Hawai'I medical Journal. Asian Pac J Trop, 69.
  31. Revaux A, Laas E, Chopier J, et al (2014). Delays in treatment of breast cancer: experience of an expert center of the Assistance Publique-Hopitaux de Paris (AP-HP). Gynecol Obstet Fertil, 42, 585-90. https://doi.org/10.1016/j.gyobfe.2014.05.005
  32. Robert AS, Vilma C, Otis WB (2009). Cancer Screening in the United States, 2009: A review of current American cancer society guidelines and issues in cancer screening. CA Cancer J, 59, 27-41. https://doi.org/10.3322/caac.20008
  33. Samah AA, Ahmadian M (2012). Socio-demographic correlates of participation in mammography: a survey among women aged between 35- 69 in Tehran, Iran. Asian Pac J Cancer Prev, 13, 2717-20. https://doi.org/10.7314/APJCP.2012.13.6.2717
  34. Sano DI, Daoud J, Lankoande J, TSS L, et al (1998). Le cancer du sein: problemes diagnostiques et therapeutiques au CHU de Ouagadougou. Medecine d'Afrique Noire, 45, 297-301.
  35. Schlichting JA, Soliman AS, Schairer C, et al (2015). Breast cancer by age at diagnosis in the Gharbiah, Egypt, population-based registry compared to the United States Surveillance, Epidemiology, and End Results Program, 2004-2008. Biomed Res Int, 2015, 381574-83
  36. Secginli S, Nahcivan NO (2011). The effectiveness of a nurse-delivered breast health promotion program on breast cancer screening behaviours in non-adherent Turkish women: A randomized controlled trial. Int J Nurs Stud, 48, 24-36 https://doi.org/10.1016/j.ijnurstu.2010.05.016
  37. Simbrich A, Wellmann I, Heidrich J, Heidinger O, Hense HW (2016). Trends in advanced breast cancer incidence rates after implementation of a mammography screening program in a German population. Cancer Epidemiol, 44, 44-51 https://doi.org/10.1016/j.canep.2016.07.006
  38. Taylor VM, Taplin SH, Urban N, White E, Peacock S (1995). Repeat mammography use among women ages 50-75. Cancer Epidemiol Biomarkers Prev, 4, 409-13
  39. Vandergrift JL, Niland JC, Theriault RL, et al (2013). Time to adjuvant chemotherapy for breast cancer in National Comprehensive Cancer Network institutions. J Natl Cancer Inst, 105, 104-12 https://doi.org/10.1093/jnci/djs506
  40. Yeoh KG, Chew L, Wang SC (2006). Cancer screening in Singapore, with particular reference to breast, cervical and colorectal cancer screening. J Med Screen, 13, S14-9 https://doi.org/10.1258/096914106776179764